TEF

3.561

-0.53%↓

KPN

4.661

-0.89%↓

TELIA1.FI

4.23

-1.86%↓

ELISA.FI

42.4

-0.61%↓

DEC

19.35

+0.16%↑

TEF

3.561

-0.53%↓

KPN

4.661

-0.89%↓

TELIA1.FI

4.23

-1.86%↓

ELISA.FI

42.4

-0.61%↓

DEC

19.35

+0.16%↑

TEF

3.561

-0.53%↓

KPN

4.661

-0.89%↓

TELIA1.FI

4.23

-1.86%↓

ELISA.FI

42.4

-0.61%↓

DEC

19.35

+0.16%↑

TEF

3.561

-0.53%↓

KPN

4.661

-0.89%↓

TELIA1.FI

4.23

-1.86%↓

ELISA.FI

42.4

-0.61%↓

DEC

19.35

+0.16%↑

TEF

3.561

-0.53%↓

KPN

4.661

-0.89%↓

TELIA1.FI

4.23

-1.86%↓

ELISA.FI

42.4

-0.61%↓

DEC

19.35

+0.16%↑

Search

Stroeer SE & Co KGaA

Closed

SectorCommunication services

29.8 -1.32

Overview

Share price change

24h

Current

Min

28.8

Max

30.8

Key metrics

By Trading Economics

Income

-2.4M

30M

Sales

-13M

492M

P/E

Sector Avg

15.769

50.178

EPS

0.441

Dividend yield

6.68

Profit margin

6.093

Employees

11,858

EBITDA

-2.7M

135M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+44.93% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

6.68%

4.43%

Next Earnings

26 mar 2026

Market Stats

By TradingEconomics

Market Cap

-447M

2.1B

Previous open

31.12

Previous close

29.8

News Sentiment

By Acuity

38%

62%

37 / 139 Ranking in Communication services

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Stroeer SE & Co KGaA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 mar 2026, 23:47 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 mar 2026, 22:55 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 mar 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 mar 2026, 23:59 UTC

Market Talk

Global Equities Roundup: Market Talk

23 mar 2026, 23:59 UTC

Market Talk

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 mar 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 mar 2026, 23:37 UTC

Market Talk

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Global Equities Roundup: Market Talk

23 mar 2026, 22:42 UTC

Market Talk
Major News Events

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 mar 2026, 22:40 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 mar 2026, 22:23 UTC

Market Talk

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 mar 2026, 22:22 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 mar 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 mar 2026, 22:20 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 mar 2026, 22:19 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 mar 2026, 22:18 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 mar 2026, 22:15 UTC

Acquisitions, Mergers, Takeovers

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 mar 2026, 22:08 UTC

Market Talk

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 mar 2026, 21:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 mar 2026, 21:42 UTC

Market Talk

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 mar 2026, 21:32 UTC

Earnings

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 mar 2026, 21:10 UTC

Major News Events

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 mar 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

23 mar 2026, 20:50 UTC

Market Talk
Earnings
Major News Events

Basic Materials Roundup: Market Talk

Peer Comparison

Price change

Stroeer SE & Co KGaA Forecast

Price Target

By TipRanks

44.93% upside

12 Months Forecast

Average 43.55 EUR  44.93%

High 60 EUR

Low 30.29 EUR

Based on 8 Wall Street analysts offering 12 month price targets forStroeer SE & Co KGaA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

4

Buy

4

Hold

0

Sell

Technical Score

By Trading Central

N/A / 52.4Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Very Strong Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

37 / 139 Ranking in Communication services

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Stroeer SE & Co KGaA

Ströer SE & Co. KGaA provides out-of-home (OOH) media and online advertising solutions in Germany and internationally. It operates through three segments: Out-of-Home Media, Digital & Dialog Media, and Data As A Service (DaaS) & E-Commerce. The company offers various OOH advertising media services, such as traditional posters media and advertisements at bus and tram shelters and on public transport; and digital advertising services. It also operates t-online.de, which publishes news, analyses, reports and interviews through digital channels; information services for digital natives through special interest portals, such as giga.de, kino.de, desired, familie.de, spieletipps.de, and SpielAffe.de; and call centers focus on customer experience and sales for telecommunications, energy, retail, financial services, and medica sectors. In addition, the company provides Statista, a platform for business data as a service that offers market and consumer data, and bundles statistical data; and asambeauty, a streaming-based live shopping beauty platform. Ströer SE & Co. KGaA was incorporated in 2016 and is based in Cologne, Germany.
help-icon Live chat